📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
TRIDENT TEXOFAB LIMITEDTTFLOther Textile Products
Open
337
High
337
Low
325.5
Close
328
Volume
2770
Exchange
bse
Time
14-Nov-2025

Outlook

Score:  

1.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Trident Texofab is  
Opening Marubozu
Estimated Stoploss of Trident Texofab is ₹  
337
Trident Texofab has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Trident Texofab has chances of  
Continuationℹ
 of the current trend. 

Trend

Trident Texofab is in  
Sideways trendℹ
. 
Price of Trident Texofab is  
Downℹ
 by  

1.26

%. 
Target
Buy @ 

210

Sell @ 

406.38

Current @ 

328

Volume

The trade volumes of Trident Texofab have become  
Deficientℹ
The volume trend for Trident Texofab is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Trident Texofab is  

Down

 by  

82.58

% 

Valuation

The current market price of Trident Texofab is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 100cr and total assets worth ₹ 100cr, the balance sheet of Trident Texofab is:  
Balancedℹ
. 
Cashflow
Trident Texofab has  
Sufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

40.63% in operatingℹ
3.13% in investingℹ
56.25% in financingℹ
0% in otherℹ
Trident Texofab has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

50% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
50% i.e. ₹ 2cr spent in financingℹ
0% in otherℹ
Income
The income of Trident Texofab is  

₹ 31cr

 and  

Profit

 is :  

₹ 1cr

(*Sep 2025)

Trident Texofab Profit is up by:  

100

% and Income is Down by:  

26.32

% 

(*Sep 2025)

The income of Trident Texofab is  

₹ 28cr

 and  

Loss

 is :  

₹ 1cr

(*Jun 2025)

Trident Texofab Losses increased by:  

0

% and Income is Up by:  

22.58

% 

(*Jun 2025)

The income of Trident Texofab is  

₹ 38cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Trident Texofab Losses increased by:  

100

% and Income is Up by:  

6.9

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.